Nisa Investment Advisors
TNGX icon

Nisa Investment Advisors’s Tango Therapeutics TNGX Stock Holding History

Nisa Investment Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151K Buy
7,240
+5,500
+316% +$76.6K ﹤0.01% 1301
2025
Q4 		$15.4K Hold
1,740
– – ﹤0.01% 2044
2025
Q3 		$14.6K Buy
1,740
+700
+67% +$4.74K ﹤0.01% 2127
2025
Q2 		$5.33K Sell
1,040
-2,590
-71% -$6.4K ﹤0.01% 2438
2025
Q1 		$4.97K Buy
+3,630
New +$8.91K ﹤0.01% 2254
2024
Q4 		– Sell
-98
Closed -$755 – 3055
2024
Q3 		$755 Sell
98
-9
-8% -$86 ﹤0.01% 2636
2024
Q2 		$918 Buy
107
+55
+106% +$425 ﹤0.01% 2536
2024
Q1 		$413 Buy
52
+27
+108% +$289 ﹤0.01% 2531
2023
Q4 		$248 Sell
25
-1,030
-98% -$8.94K ﹤0.01% 2523
2023
Q3 		$11.9K Buy
+1,055
New +$6.43K ﹤0.01% 2141
2023
Q1 		– Sell
-14,290
Closed -$104K – 2706
2022
Q4 		$104K Buy
14,290
+52
+0.4% +$366 ﹤0.01% 1546
2022
Q3 		$105K Buy
+14,238
New +$60.8K ﹤0.01% 1489

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Nisa Investment Advisors's TNGX Position: Q1 2026 in Review

Nisa Investment Advisors increased its Tango Therapeutics (TNGX) stake by 316% in Q1 2026, buying an estimated $76.6K and bringing the position to 7,240 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #1301.

Nisa Investment Advisors first reported a position in TNGX in Q3 2022 and has held it in 12 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Nisa Investment Advisors held 7,240 shares of Tango Therapeutics worth $151K as of Q1 2026.
  • Nisa Investment Advisors bought 5,500 Tango Therapeutics shares in Q1 2026, an estimated $76.6K.
  • Tango Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1301 holding.
  • Nisa Investment Advisors first reported a position in Tango Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.